We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter Presents Virtual Showcase of MicroScan Microbiology Solutions

By LabMedica International staff writers
Posted on 25 Apr 2022

Beckman Coulter (Brea, CA, USA) demonstrated how laboratories can improve patient outcomes with accurate detection of antimicrobial resistance and enhance workflow efficiency with its MicroScan microbiology solutions at ECCMID 2022. More...

Emerging antimicrobial resistance continues to be a critical issue in today’s healthcare environment. Resistance that was once considered unusual is now routine, and the microbiology laboratory has increasingly many ways, including rapid methods, to test for antimicrobial resistance. Beckman Coulter’s integrated symposium at ECCMID 2022 examined the central role of susceptibility testing and the determination of MICs in a variety of laboratory health care settings. Topics examined included new mechanisms of resistance, laboratory testing protocols and standardization across organizations, and the importance of MICs as well as SIR categories in defining antibiotic treatment, particularly with new antibiotics.

In addition, Beckman Coulter displayed its full suite of MicroScan microbiology solutions designed for every laboratory through its virtual showcase in 3D. Among its innovations for managing emerging microbial resistance that were presented virtually was the company’s DxM MicroScan WalkAway ID/AST System for the detection of emerging and critical antimicrobial resistance with gold-standard1 MIC accuracy. Designed with ease of use as a focal point, this bacterial identification and antimicrobial susceptibility testing (ID/AST) system provides streamlined workflows and enhanced performance compared to its predecessors. It enables laboratories to optimize patient care while reducing risks, costs and operational burden associated with detecting emerging antimicrobial resistance.

Related Links:
Beckman Coulter 


New
Gold Member
Latex Test
SLE-Latex Test
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Assay
Fecal Calprotectin ELISA
New
Unstirred Waterbath
HumAqua 5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.